| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 77E89833TG |
Pharmacology
| Action | Mechanism of Action | Reference | |
|---|---|---|---|
| INHIBITOR | Hepatocyte growth factor inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference | ||
|---|---|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials | ||
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials | ||
| Glioblastoma | 1 | D005909 | ClinicalTrials | ||
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials | ||
| Multiple Myeloma | 1 | D009101 | ClinicalTrials | ||
| Carcinoma, Squamous Cell | 1 | D002294 | ClinicalTrials | ||
| Carcinoma, Squamous Cell | 1 | D002294 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1174900-84-5 |
| ChEMBL | CHEMBL1743018 |
| FDA SRS | 77E89833TG |
CONTENTS